184 related articles for article (PubMed ID: 20835371)
1. Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation.
Davis AA; Heilman CJ; Brady AE; Miller NR; Fuerstenau-Sharp M; Hanson BJ; Lindsley CW; Conn PJ; Lah JJ; Levey AI
ACS Chem Neurosci; 2010 Aug; 1(8):542-551. PubMed ID: 20835371
[TBL] [Abstract][Full Text] [Related]
2. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
[TBL] [Abstract][Full Text] [Related]
3. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
[TBL] [Abstract][Full Text] [Related]
4. FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists.
Markovic D; Holdich J; Al-Sabah S; Mistry R; Krasel C; Mahaut-Smith MP; Challiss RA
PLoS One; 2012; 7(1):e29946. PubMed ID: 22272263
[TBL] [Abstract][Full Text] [Related]
5. Role of Conserved Tyrosine Lid Residues in the Activation of the M
Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
[TBL] [Abstract][Full Text] [Related]
6. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
[TBL] [Abstract][Full Text] [Related]
7. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
[TBL] [Abstract][Full Text] [Related]
8. Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
Sheffler DJ; Sevel C; Le U; Lovell KM; Tarr JC; Carrington SJ; Cho HP; Digby GJ; Niswender CM; Conn PJ; Hopkins CR; Wood MR; Lindsley CW
Bioorg Med Chem Lett; 2013 Jan; 23(1):223-7. PubMed ID: 23200253
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
[TBL] [Abstract][Full Text] [Related]
10. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of muscarinic acetylcholine receptors.
Gregory KJ; Sexton PM; Christopoulos A
Curr Neuropharmacol; 2007 Sep; 5(3):157-67. PubMed ID: 19305798
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
Thomas RL; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
[TBL] [Abstract][Full Text] [Related]
13. Regulation of muscarinic acetylcholine receptor signaling.
van Koppen CJ; Kaiser B
Pharmacol Ther; 2003 May; 98(2):197-220. PubMed ID: 12725869
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.
Keov P; López L; Devine SM; Valant C; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
J Biol Chem; 2014 Aug; 289(34):23817-37. PubMed ID: 25006252
[TBL] [Abstract][Full Text] [Related]
15. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
Digby GJ; Shirey JK; Conn PJ
Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
[TBL] [Abstract][Full Text] [Related]
16. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
[TBL] [Abstract][Full Text] [Related]
18. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.
Conn PJ; Jones CK; Lindsley CW
Trends Pharmacol Sci; 2009 Mar; 30(3):148-55. PubMed ID: 19201489
[TBL] [Abstract][Full Text] [Related]
19. Multitargeting nature of muscarinic orthosteric agonists and antagonists.
Myslivecek J
Front Physiol; 2022; 13():974160. PubMed ID: 36148314
[TBL] [Abstract][Full Text] [Related]
20. The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors.
Volpato D; Kauk M; Messerer R; Bermudez M; Wolber G; Bock A; Hoffmann C; Holzgrabe U
ACS Omega; 2020 Dec; 5(49):31706-31715. PubMed ID: 33344823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]